实时全球研报
SGH Ltd FY26 result: SOTP supportive, but lacking certainty on growth drivers
研报英文原文证据摘录
J P M O R G A N
Asia Pacific Equity Research
11 August 2026
SGH Ltd
FY26 result: SOTP supportive, but lacking certainty on
growth drivers
Neutral
SGH.AX, SGH AU
Price (11 Aug 26):A$41.58
▲Price Target (Aug-27):A$43.00
Prior (Jul-27):A$42.90
The FY26 result came in weaker than JPMe and the market had expected, with
EBIT of $1,554m -2%/-1% vs. JPMe/consensus (NPAT 5%/4% below JPMe/
consensus). Although SGH has SOTP support, today’s result suggests that growth
rates are unlikely to accelerate without M&A in the near term (something that
remains uncertain despite balance sheet capacity). While management continues
to drive operational improvement, we assume that SGH will generate a low-singledigit EBIT CAGR till FY28, given headwinds across: (1) Coates (competition);
and (2) Boral (our view is that end markets decline from 2HFY28) that are not fully
offset by: (3) Crux/Energy (FY28E); and a recovery in (4) WesTrac (which faces
a less certain long-term outlook). While there are other clear positives out of
today’s result (noting the property portfolio and opportunity to organically grow
the existing business), these will likely take longer to generate meaningful returns.
Our SOTP valuation is $43/share (was $42.90), and we remain at Neutral.
Boral 2H26 margin disappointment, recovery in FY27, but cycle still
matters: 2H EBIT margin of 13.5% came in 100bps below our estimate (in part
due to less over-recovery of diesel price than we had assumed). Despite this,
we expect margin expansion back to a ~15% EBIT margin in FY27, supported
by cost initiatives across labor and transport, with potential upside from the
Asphalt business (~18% of Boral earnings). We expect FY29 to be pressured
by a reduction in infrastructure projects (and a slower-than-expected
residential ramp). After this, earnings should be supported by the Brisbane
Olympics (as with Coates).
FX impacting WesTrac sales growth in FY27: WesTrac delivered EBIT
of $647m (+1% YoY) as capital sales normalised back to the lower end of the
normal $1.6b-1.8b range. We assume -1% EBIT growth in FY27, with FX not
fully offset by cost reductions. Looking beyond FY27, management expressed
…
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器